Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report) has earned an average rating of “Moderate Buy” from the five research ...

The Orthofix SpinalStim you’re seeing here was given to me by a friend after their doctor said the therapy could be cut short. This provided a somewhat rare opportunity to observe the device ...

Julie Andrews, the Chief Financial Officer of Orthofix Medical (TASE:PMCN) Inc. (NASDAQ:OFIX), recently sold a portion of her holdings in the company. According to a recent filing, Andrews sold ...

Stifel has upgraded Orthofix Medical (NASDAQ:OFIX) to buy from hold, citing the company's new management, underappreciated earnings power and cash flow generation. The investment bank said it has ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San ...

Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $17 ...

The analyst is optimistic about Orthofix Medical's unique offerings and plans for ongoing innovation. 7D and ortho sub-segments are in Orthofix Medical's highest growing markets. Get two weeks of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Presents Shares and Regional Growth Trends for Cortical, Cancellous, and Hybrid Screws Segmented by Application and End UseDublin, Feb. 07, ...

Intercontinental Exchange and RELX are among the stocks that are now expensive. We sell different types of products and services to both investment professionals and individual investors. These ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...